David M. Pollock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David M. Pollock has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
Joshua S. Speed
Cardio-Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
11 shared publicationsJennifer S. Pollock
Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA; Cardio-Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
6 shared publicationsChunhua Jin
Univ of Alabama at Birmingham, Birmingham, AL
5 shared publicationsEman Y. Gohar
Cardio-Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
4 shared publicationsMalgorzata Kasztan
Cardio-Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama
4 shared publications- Brandon M. Fox
Cardio-Renal Physiology and Medicine, Department of Medicine, and
3 shared publications
Latest Publications
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract P217: Evidence for Impaired Diurnal Cardio-Vagal Tone Due to p67phox in Dahl Salt-Sensitive Rats
Salt-sensitive hypertension is associated with increased reactive oxygen species (ROS) generation and sympathetic tone, and diurnal alterations in the rhythm of blood pressure control further increase cardiovascular disease risk. However, the interaction between ROS and diurnal autonomic rhythms is unclear. We hypothesized that ROS generation impairs diurnal autonomic tone in the Dahl salt-sensitive model of hypertension. Dahl salt-sensitive (Dahl SS; n=14), Dahl SS p67phox null (SSp67; n=8), and Dahl SS with an introgressed chromosome 13 from Brown-Norway (SS.BN13; n=7) rats were instrumented with telemetry transmitters and fed a normal (0.4% NaCl), low (0.04% NaCl), or high salt (4.0% NaCl) diet. Data were analyzed on days 7 - 10 of each diet. SSp67 and SS.BN13 have lower blood pressure than Dahl SS on high salt diet. Surprisingly, we saw no difference between groups in 24-hr heart rate or systolic blood pressure low frequency to high frequency (LF/HF) on each diet suggesting a similar 24-hr autonomic tone across genotypes. However, SSp67 had a reduced LF/HF amplitude (day-night) compared to Dahl SS during high salt (0.36 ± 0.05 vs. 0.67 ± 0.11 LF/HF; respectively p=0.01). SSp67 also had higher 24-hr root mean squared of successive differences (RMSSD), a marker of cardio-vagal tone, within each salt diet (table). Also, RMSSD amplitude was higher in SSp67 (table) than other groups within each salt diet. These results support the hypothesis that reductions in cardio-vagal tone and diurnal autonomic function in the Dahl SS rat is due to NADPH oxidase activity, most likely via production of ROS. Inhibition of ROS may be an effective therapy to improve diurnal cardio-vagal tone.
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract P217: Evidence for Impaired Diurnal Cardio-Vagal Tone Due to p67phox in Dahl Salt-Sensitive Rats
Salt-sensitive hypertension is associated with increased reactive oxygen species (ROS) generation and sympathetic tone, and diurnal alterations in the rhythm of blood pressure control further increase cardiovascular disease risk. However, the interaction between ROS and diurnal autonomic rhythms is unclear. We hypothesized that ROS generation impairs diurnal autonomic tone in the Dahl salt-sensitive model of hypertension. Dahl salt-sensitive (Dahl SS; n=14), Dahl SS p67phox null (SSp67; n=8), and Dahl SS with an introgressed chromosome 13 from Brown-Norway (SS.BN13; n=7) rats were instrumented with telemetry transmitters and fed a normal (0.4% NaCl), low (0.04% NaCl), or high salt (4.0% NaCl) diet. Data were analyzed on days 7 - 10 of each diet. SSp67 and SS.BN13 have lower blood pressure than Dahl SS on high salt diet. Surprisingly, we saw no difference between groups in 24-hr heart rate or systolic blood pressure low frequency to high frequency (LF/HF) on each diet suggesting a similar 24-hr autonomic tone across genotypes. However, SSp67 had a reduced LF/HF amplitude (day-night) compared to Dahl SS during high salt (0.36 ± 0.05 vs. 0.67 ± 0.11 LF/HF; respectively p=0.01). SSp67 also had higher 24-hr root mean squared of successive differences (RMSSD), a marker of cardio-vagal tone, within each salt diet (table). Also, RMSSD amplitude was higher in SSp67 (table) than other groups within each salt diet. These results support the hypothesis that reductions in cardio-vagal tone and diurnal autonomic function in the Dahl SS rat is due to NADPH oxidase activity, most likely via production of ROS. Inhibition of ROS may be an effective therapy to improve diurnal cardio-vagal tone.
- 1 January 2018
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 12 (1) , 34-41
Relation of urinary endothelin-1 to stress-induced pressure natriuresis in healthy adolescents
- 1 January 2018
- Published by Elsevier in Journal of the American Society of Hypertension
- Vol. 12 (1) , 34-41
Relation of urinary endothelin-1 to stress-induced pressure natriuresis in healthy adolescents
- 1 August 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 313 (2) , F361-F369
Ovariectomy uncovers purinergic receptor activation of endothelin-dependent natriuresis
We recently reported that natriuresis produced by renal medullary salt loading is dependent on endothelin (ET)-1 and purinergic (P2) receptors in male rats. Because sex differences in ET-1 and P2 signaling have been reported, we decided to test whether ovarian sex hormones regulate renal medullary ET-1 and P2-dependent natriuresis. The effect of medullary NaCl loading on Na+excretion was determined in intact and ovariectomized (OVX) female Sprague-Dawley rats with and without ET-1 or P2 receptor antagonism. Isosmotic saline (284 mosmol/kgH2O) was infused in the renal medullary interstitium of anesthetized rats during a baseline urine collection period, followed by isosmotic or hyperosmotic saline (1,800 mosmol/kgH2O) infusion. Medullary NaCl loading significantly enhanced Na+excretion in intact and OVX female rats. ETA+Bor P2 receptor blockade did not attenuate the natriuretic effect of medullary NaCl loading in intact females, whereas ETA+Bor P2 receptor blockade attenuated the natriuretic response to NaCl loading in OVX rats. Activation of medullary P2Y2and P2Y4receptors by UTP infusion had no significant effect in intact females but enhanced Na+excretion in OVX rats. Combined ETA+Breceptor blockade significantly inhibited the natriuretic response to UTP observed in OVX rats. These data demonstrate that medullary NaCl loading induces ET-1 and P2-independent natriuresis in intact females. In OVX, activation of medullary P2 receptors promotes ET-dependent natriuresis, suggesting that ovarian hormones may regulate the interplay between the renal ET-1 and P2 signaling systems to facilitate Na+excretion.
- 1 August 2017
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 313 (2) , F361-F369
Ovariectomy uncovers purinergic receptor activation of endothelin-dependent natriuresis
We recently reported that natriuresis produced by renal medullary salt loading is dependent on endothelin (ET)-1 and purinergic (P2) receptors in male rats. Because sex differences in ET-1 and P2 signaling have been reported, we decided to test whether ovarian sex hormones regulate renal medullary ET-1 and P2-dependent natriuresis. The effect of medullary NaCl loading on Na+excretion was determined in intact and ovariectomized (OVX) female Sprague-Dawley rats with and without ET-1 or P2 receptor antagonism. Isosmotic saline (284 mosmol/kgH2O) was infused in the renal medullary interstitium of anesthetized rats during a baseline urine collection period, followed by isosmotic or hyperosmotic saline (1,800 mosmol/kgH2O) infusion. Medullary NaCl loading significantly enhanced Na+excretion in intact and OVX female rats. ETA+Bor P2 receptor blockade did not attenuate the natriuretic effect of medullary NaCl loading in intact females, whereas ETA+Bor P2 receptor blockade attenuated the natriuretic response to NaCl loading in OVX rats. Activation of medullary P2Y2and P2Y4receptors by UTP infusion had no significant effect in intact females but enhanced Na+excretion in OVX rats. Combined ETA+Breceptor blockade significantly inhibited the natriuretic response to UTP observed in OVX rats. These data demonstrate that medullary NaCl loading induces ET-1 and P2-independent natriuresis in intact females. In OVX, activation of medullary P2 receptors promotes ET-dependent natriuresis, suggesting that ovarian hormones may regulate the interplay between the renal ET-1 and P2 signaling systems to facilitate Na+excretion.
- Open Access
- 27 March 2017
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 28 (8) , 2443-2458
Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice
Sickle cell disease (SCD)–associated nephropathy is a major source of morbidity and mortality in patients because of the lack of efficacious treatments targeting renal manifestations of the disease. Here, we describe a long-term treatment strategy with the selective endothelin-A receptor (ETA) antagonist, ambrisentan, designed to interfere with the development of nephropathy in a humanized mouse model of SCD. Ambrisentan preserved GFR at the level of nondisease controls and prevented the development of proteinuria, albuminuria, and nephrinuria. Microscopy studies demonstrated prevention of podocyte loss and structural alterations, the absence of vascular congestion, and attenuation of glomerulosclerosis in treated mice. Studies in isolated glomeruli showed that treatment reduced inflammation and oxidative stress. At the level of renal tubules, ambrisentan treatment prevented the increased excretion of urinary tubular injury biomarkers. Additionally, the treatment strategy prevented tubular brush border loss, diminished tubular iron deposition, blocked the development of interstitial fibrosis, and prevented immune cell infiltration. Furthermore, the prevention of albuminuria in treated mice was associated with preservation of cortical megalin expression. In a separate series of identical experiments, combined ETA and ETB receptor antagonism provided only some of the protection observed with ambrisentan, highlighting the importance of exclusively targeting the ETA receptor in SCD. Our results demonstrate that ambrisentan treatment provides robust protection from diverse renal pathologies in SCD mice, and suggest that long-term ETA receptor antagonism may provide a strategy for the prevention of renal complications of SCD.
- 27 March 2017
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 28 (8) , 2443-2458
Open AccessLong-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice
Sickle cell disease (SCD)–associated nephropathy is a major source of morbidity and mortality in patients because of the lack of efficacious treatments targeting renal manifestations of the disease. Here, we describe a long-term treatment strategy with the selective endothelin-A receptor (ETA) antagonist, ambrisentan, designed to interfere with the development of nephropathy in a humanized mouse model of SCD. Ambrisentan preserved GFR at the level of nondisease controls and prevented the development of proteinuria, albuminuria, and nephrinuria. Microscopy studies demonstrated prevention of podocyte loss and structural alterations, the absence of vascular congestion, and attenuation of glomerulosclerosis in treated mice. Studies in isolated glomeruli showed that treatment reduced inflammation and oxidative stress. At the level of renal tubules, ambrisentan treatment prevented the increased excretion of urinary tubular injury biomarkers. Additionally, the treatment strategy prevented tubular brush border loss, diminished tubular iron deposition, blocked the development of interstitial fibrosis, and prevented immune cell infiltration. Furthermore, the prevention of albuminuria in treated mice was associated with preservation of cortical megalin expression. In a separate series of identical experiments, combined ETA and ETB receptor antagonism provided only some of the protection observed with ambrisentan, highlighting the importance of exclusively targeting the ETA receptor in SCD. Our results demonstrate that ambrisentan treatment provides robust protection from diverse renal pathologies in SCD mice, and suggest that long-term ETA receptor antagonism may provide a strategy for the prevention of renal complications of SCD.
- 1 November 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 311 (5) , F991-F998
Loss of endothelin B receptor function impairs sodium excretion in a time- and sex-dependent manner
Recent studies suggested a direct link between circadian rhythms and regulation of sodium excretion. Endothelin-1 (ET-1) regulates sodium balance by promoting natriuresis through the endothelin B receptor (ETB) in response to increased salt in the diet, but the effect that the time of day has on this natriuretic response is not known. Therefore, this study was designed to test the hypothesis that ETBreceptor activation contributes to the diurnal control of sodium excretion and that sex differences contribute to this control as well. Twelve-hour urine collections were used to measure sodium excretion. On day 3 of the experiment, a NaCl load (900 μeq) was given by oral gavage either at Zeitgeber time [ZT] 0 (inactive period) or ZT12 (active period) to examine the natriuretic response to the acute salt load. Male and female ETB-deficient (ETBdef) rats showed an impaired natriuretic response to a salt load at ZT0 compared with their respective transgenic controls (Tg cont). Male ETBdef rats showed a delayed natriuretic response to a salt load given at ZT12 compared with male Tg cont, a contrast to the prompt response shown by female ETBdef rats. Treatment with ABT-627, an ETAreceptor antagonist, improved the natriuretic response seen within the first 12 h of a ZT0 salt load in both sexes. These findings demonstrate that diurnal excretion of an acute salt load 1) requires ET-1 and the ETBreceptor, 2) is more evident in male vs. female rats, and 3) is opposed by the ETAreceptor.
- 1 November 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 311 (5) , F991-F998
Loss of endothelin B receptor function impairs sodium excretion in a time- and sex-dependent manner
Recent studies suggested a direct link between circadian rhythms and regulation of sodium excretion. Endothelin-1 (ET-1) regulates sodium balance by promoting natriuresis through the endothelin B receptor (ETB) in response to increased salt in the diet, but the effect that the time of day has on this natriuretic response is not known. Therefore, this study was designed to test the hypothesis that ETBreceptor activation contributes to the diurnal control of sodium excretion and that sex differences contribute to this control as well. Twelve-hour urine collections were used to measure sodium excretion. On day 3 of the experiment, a NaCl load (900 μeq) was given by oral gavage either at Zeitgeber time [ZT] 0 (inactive period) or ZT12 (active period) to examine the natriuretic response to the acute salt load. Male and female ETB-deficient (ETBdef) rats showed an impaired natriuretic response to a salt load at ZT0 compared with their respective transgenic controls (Tg cont). Male ETBdef rats showed a delayed natriuretic response to a salt load given at ZT12 compared with male Tg cont, a contrast to the prompt response shown by female ETBdef rats. Treatment with ABT-627, an ETAreceptor antagonist, improved the natriuretic response seen within the first 12 h of a ZT0 salt load in both sexes. These findings demonstrate that diurnal excretion of an acute salt load 1) requires ET-1 and the ETBreceptor, 2) is more evident in male vs. female rats, and 3) is opposed by the ETAreceptor.
- Open Access
- 1 September 2016
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 40 (3) , 275-277
Comprehensive Physiology: a tool for advanced education in physiology
- 1 September 2016
- Published by American Physiological Society in Advances in Physiology Education
- Vol. 40 (3) , 275-277
Open AccessComprehensive Physiology: a tool for advanced education in physiology
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 2-9
The Fourteenth International Conference on Endothelin (ET-14), Savannah, U.S.A.
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 2-9
The Fourteenth International Conference on Endothelin (ET-14), Savannah, U.S.A.
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 10-11
The Third Tomoh Masaki Award (2015)
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 10-11
The Third Tomoh Masaki Award (2015)
- 1 August 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 311 (2) , F260-F267
Activation of purinergic receptors (P2) in the renal medulla promotes endothelin-dependent natriuresis in male rats
Renal endothelin-1 (ET-1) and purinergic signaling systems regulate Na+reabsorption in the renal medulla. A link between the renal ET-1 and purinergic systems was demonstrated in vitro, however, the in vivo interaction between these systems has not been defined. To test whether renal medullary activation of purinergic (P2) receptors promotes ET-dependent natriuresis, we determined the effect of increased medullary NaCl loading on Na+excretion and inner medullary ET-1 mRNA expression in anesthetized adult male Sprague-Dawley rats in the presence and absence of purinergic receptor antagonism. Isosmotic saline (NaCl; 284 mosmol/kgH2O) was infused into the medullary interstitium (500 μl/h) during a 30-min baseline urine collection period, followed by isosmotic or hyperosmotic saline (1,800 mosmol/kgH2O) for two further 30-min urine collection periods. Na+excretion was significantly increased during intramedullary infusion of hyperosmotic saline. Compared with isosmotic saline, hyperosmotic saline infused into the renal medulla caused significant increases in inner medullary ET-1 mRNA expression. Renal intramedullary infusion of the P2 receptor antagonist suramin inhibited the increase in Na+excretion and inner medullary ET-1 mRNA expression induced by NaCl loading in the renal medulla. Activation of medullary P2Y2/4receptors by infusion of UTP increased urinary Na+excretion. Combined ETAand ETBreceptor blockade abolished the natriuretic response to intramedullary infusion of UTP. These data demonstrate that activation of medullary P2 receptors promotes ET-dependent natriuresis in male rats, suggesting that the renal ET-1 and purinergic signaling systems interact to efficiently facilitate excretion of a NaCl load.
- 1 August 2016
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 311 (2) , F260-F267
Activation of purinergic receptors (P2) in the renal medulla promotes endothelin-dependent natriuresis in male rats
Renal endothelin-1 (ET-1) and purinergic signaling systems regulate Na+reabsorption in the renal medulla. A link between the renal ET-1 and purinergic systems was demonstrated in vitro, however, the in vivo interaction between these systems has not been defined. To test whether renal medullary activation of purinergic (P2) receptors promotes ET-dependent natriuresis, we determined the effect of increased medullary NaCl loading on Na+excretion and inner medullary ET-1 mRNA expression in anesthetized adult male Sprague-Dawley rats in the presence and absence of purinergic receptor antagonism. Isosmotic saline (NaCl; 284 mosmol/kgH2O) was infused into the medullary interstitium (500 μl/h) during a 30-min baseline urine collection period, followed by isosmotic or hyperosmotic saline (1,800 mosmol/kgH2O) for two further 30-min urine collection periods. Na+excretion was significantly increased during intramedullary infusion of hyperosmotic saline. Compared with isosmotic saline, hyperosmotic saline infused into the renal medulla caused significant increases in inner medullary ET-1 mRNA expression. Renal intramedullary infusion of the P2 receptor antagonist suramin inhibited the increase in Na+excretion and inner medullary ET-1 mRNA expression induced by NaCl loading in the renal medulla. Activation of medullary P2Y2/4receptors by infusion of UTP increased urinary Na+excretion. Combined ETAand ETBreceptor blockade abolished the natriuretic response to intramedullary infusion of UTP. These data demonstrate that activation of medullary P2 receptors promotes ET-dependent natriuresis in male rats, suggesting that the renal ET-1 and purinergic signaling systems interact to efficiently facilitate excretion of a NaCl load.
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 148-152
Ovarian hormones modulate endothelin A and B receptor expression
- 1 August 2016
- Published by Elsevier in Life Sciences
- Vol. 159, 148-152
Ovarian hormones modulate endothelin A and B receptor expression